Citations

Showing 10 of 108152 citations.

Hi-Plex2: A Simple and Robust Approach to Targeted Sequencing-Based Genetic Screening
Hammet, Fleur, Mahmood, Khalid , Green, Thomas R, Nguyen‐Dumont, Tú , Buchanan, Daniel D. , Lonie, Andrew , Nathanson, Katherine L. , Pope, Bernard J. , Buchanan, Daniel D , Nathanson, Katherine L , Nguyen-Dumont, Tu , Pope, Bernard J , Southey, Melissa C. , Couch, Fergus J. , Park, Daniel J.

Mayo Clinic

BioTechniques | July 3, 2019 | Volume: 67 | Issue: 3 | Pages: 118-122

10.2144/btn-2019-0026 | PMID 31267764 Get It

First Robot-Assisted Laparoscopic Pyeloplasty Utilizing the da Vinci SP System
Agarwal, Deepak , Chow, George K. , Frank, Igor, Tollefson, Matthew K. , Gettman, Matthew T., Viers, Boyd R.

Mayo Clinic

Videourology™ | July 3, 2019 | Volume: 33 | Issue: 4 | Pages: No page available

10.1089/vid.2018.0051 Get It

SAGE-Journals-Accessible-Video-Player 10.1089/vid.2018.0051.M1 sj-vid-1-vid-10.1089_vid.2018.0051
Recent advances towards gene therapy for propionic acidemia: translation to the clinic
Barry, Michael A. , Barry, Michael A

Mayo Clinic

Expert Review of Precision Medicine and Drug Development | July 3, 2019 | Volume: 4 | Issue: 4 | Pages: 229-237

10.1080/23808993.2019.1635883 Get It

Faculty Opinions recommendation of Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis.
Kumar, Rajiv

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 3, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.736021196.793561734 Get It

Cryptococcusneoformans pericarditis in a lung transplant recipient: Case report, literature review and pearls
Helou, Guy El , Hellinger, Walter C. , El Helou, Guy , Hellinger, Walter

Mayo Clinic

Transplant Infectious Disease | July 3, 2019 | Volume: 21 | Issue: 5 | Pages: No page available

10.1111/tid.13137 | PMID 31267603 Get It

AbstractA 68‐year‐old man presented for outpatient evaluation of dyspnea and new‐onset atrial fibrillation 9 months after undergoing bilateral lung transplantation. Echocardiography prior to cardioversion raised concern for tamponade. Therapeutic pericardiocentesis returned fluid containing 1875 wbc/mcl (68% pmn) and yielded Cryptococcus neoformans in culture. Cryptococcal antigen was detected in serum at a titer of 1:20. Cerebrospinal (CSF) fluid was without evidence of inflammation and without detectable cryptococcal antigen. There was no radiographic evidence of pulmonary cryptococcosis. Cultures of blood and CSF were without growth. Liposomal amphotericin B (3 mg/kg/day) was administered for 15 days. Oral fluconazole was added on day seven of amphotericin, and the patient was discharged to home 3 days later. Daily dosages of prednisone (10 mg), mycophenolate (500 mg), and tacrolimus (3 mg) at discharge were the same as at hospital admission. He was readmitted 12 days later with dyspnea and with re‐accumulation and loculation of pericardial fluid. A pericardial window was created. Pericardial fluid contained 722 wbc/mcl (35% pmn); Cryptococcus was not identified on direct examinations or cultures of pericardial fluid or tissue. Cryptococcus antigen was present in serum at 1:160. Liposomal amphotericin B was resumed and continued for 2 weeks followed by resumption of fluconazole. Mycophenolate was stopped. Prednisone and tacrolimus were continued. Restrictive pericarditis was evident 3 weeks after window creation. Colchicine was initiated, prednisone increased to 15 mg daily and pericardiectomy planned. We aim to raise awareness to Cryptococcus as a potential etiology for pericarditis in solid organ transplant recipients.
Type 1 equilibrative nucleoside transporter (ENT1) regulates sex‐specific ethanol drinking during disruption of circadian rhythms
Jia, Yun‐Fang , Vadnie, Chelsea A. , Ho, Ada Man‐Choi , Peyton, Lee , Wininger, Katheryn M. , Matveyenko, Aleksey V. , Wininger, Katheryn, Matveyenko, Aleksey, Ho, Ada M-C , Veldić, Marin , Choi, Doo‐Sup

Mayo Clinic

Addiction Biology | July 3, 2019 | Volume: 25 | Issue: 5 | Pages: No page available

10.1111/adb.12801 | PMID 31267611 Get It

AbstractDisruptions in circadian rhythms are risk factors for excessive alcohol drinking. The ethanol‐sensitive adenosine equilibrative nucleoside transporter type 1 (ENT1, slc29a1) regulates ethanol‐related behaviors, sleep, and entrainment of circadian rhythms. However, the mechanism underlying the increased ethanol consumption in ENT1 knockout (KO) mice in constant light (LL) and whether there are sex differences in ethanol consumption in ENT1 mice are less studied. Here, we investigated the effects of loss of ENT1, LL, and sex on ethanol drinking using two‐bottle choice. In addition, we monitored the locomotor activity rhythms. We found that LL increased ethanol drinking and reduced accumbal ENT1 expression and adenosine levels in male but not female mice, compared with control mice. Interestingly, only LL‐exposed male, not female, ENT1 KO mice exhibited higher ethanol drinking and a longer circadian period with a higher amplitude compared with wild‐type (WT) mice. Furthermore, viral‐mediated rescue of ENT1 expression in the NAc of ENT1 KO mice reduced ethanol drinking, demonstrating a possible causal link between ENT1 expression and ethanol drinking in males. Together, our findings indicate that deficiency of ENT1 expression contributes to excessive ethanol drinking in a sex‐dependent manner.
Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine
Doty, Erin , Krege, John H. , Jin, Leah, Raskin, Joel, Kalidas, Kavita, Halker Singh, Rashmi B, Singh, Rashmi B. Halker

Mayo Clinic

Cephalalgia | July 3, 2019 | Volume: 39 | Issue: 12 | Pages: 1569-1576

10.1177/0333102419859313 | PMID 31266353 Get It

Background Sustained pain freedom is an important attribute of acute migraine therapies for patients and physicians. Here we report efficacy of the centrally penetrant, highly selective, 5-HT 1F agonist lasmiditan on sustained pain freedom and other outcomes at 24 and 48 hours post-dose. Study design and methods Data from the similarly designed, Phase 3, double-blind studies SAMURAI (NCT02439320) and SPARTAN (NCT02605174) were pooled to more precisely estimate efficacy effects in these post-hoc analyses. In both studies, inclusion criteria were 3–8 migraine attacks per month and Migraine Disability Assessment Score of ≥ 11 (at least moderate disability). Patients were randomized equally to lasmiditan 200 mg, 100 mg, 50 mg (50 mg only in SPARTAN), or to placebo. The study drug was to be taken within 4 hours of onset of pain for non-improving headache of at least moderate severity. Sustained pain freedom was defined as being pain free at 2 hours and at the given time point (24 or 48 hours) post-dose without use of additional study drug or migraine medications. Sustained responses were assessed similarly for most bothersome symptom-free, total migraine-free, and disability-free outcomes. For comparisons with previously published data on other acute medications, an additional endpoint of modified sustained pain freedom at 24 hours was defined as being pain free at 2 hours and no moderate-to-severe headache at 24 hours post-dose without use of additional study drug or migraine medications. Results Significantly higher proportions of patients treated with lasmiditan versus placebo achieved headache pain freedom at 2 hours post-dose: 200 mg: 35.6%; 100 mg: 29.9%; 50 mg: 28.6%; placebo: 18.3% (all p < 0.001). Sustained pain freedom was significantly higher in patients treated with lasmiditan versus placebo at 24 hours: 200 mg: 21.2%; 100 mg: 16.9%; 50 mg: 17.4%; placebo: 10.3% (all p < 0.01); and at 48 hours: 200 mg: 18.4%; 100 mg: 15.2%; 50 mg: 14.9%; placebo: 9.6% (all p < 0.05). Similar sustained benefits of lasmiditan versus placebo at 24 and 48 hours were noted for most bothersome symptom-free, total migraine-free and disability-free responses. Modified sustained pain freedom at 24 hours was also observed in significantly higher proportions of lasmiditan-treated patients versus placebo: 200 mg: 27.0%; 100 mg: 21.7%; 50 mg: 21.7%; placebo: 12.9% (all p < 0.01). Conclusion Sustained responses at 24 and 48 hours were noted in significantly more patients treated with lasmiditan versus placebo for several efficacy outcomes including pain freedom, most bothersome symptom-free, total migraine-free and disability-free responses. Clinicaltrials.gov identifier numbers SAMURAI: NCT02439320; SPARTAN: NCT02605174.
Mandibular Tori Limiting Treatment of Carcinoma of the Upper Aerodigestive Tract
Low, Christopher M. , Kasperbauer, Jan L. , Price, Daniel L.

Mayo Clinic

Clinical Medicine Insights: Case Reports | July 3, 2019 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/1179547619856599 | PMID 31320809 Get It

Background: Mandibular tori are a rare cause of difficult direct visualization of the upper aerodigestive tract. In the setting of aerodigestive tract pathology necessitating direct visualization, removal of mandibular tori may be required to facilitate treatment. Methods: In the first case, large bilateral symmetric mandibular tori were removed to facilitate access to the anterior commissure and removal of a T1 glottic squamous cell carcinoma (SCC). In the second case, large bilateral mandibular tori were removed to access a markedly exophytic SCC in the right vallecula. Subsequently, the tumor was removed with robotic assistance with excellent exposure. Results: Both patients were free of recurrence at last follow-up. Conclusion: Mandibular tori are an uncommon cause of difficult direct laryngoscopy. In situations that require direct visualization of the anterior commissure or base of tongue for diagnosis and management of lesions, surgical removal of the tori may be required as in the cases presented here.
Progressive Back Pain due toAspergillus nidulansVertebral Osteomyelitis in an Immunocompetent Patient: Surgical and Antifungal Management
Lyons, Mark , Neal, Matthew T. , Vikram, Holenarasipur R. , Lyons, Mark K , Patel, Naresh P. , Vikram, Holenarasipur R.

Mayo Clinic

Case Reports in Orthopedics | July 2, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-4

10.1155/2019/4268468 | PMID 31355034 Get It

Case Report.Aspergillusosteomyelitis is a destructive and progressive infection that has been described both in immunosuppressed and in immunocompetent hosts. We describe a case of lumbar vertebral osteomyelitis in a 61-year-old immunocompetent patient due toAspergillus nidulansthat was successfully treated with a combination of extensive surgical debridement, spinal stabilization, and a prolonged course of antifungal therapy. Imaging demonstrated findings consistent with L3 discitis. The biopsy grewAspergillusfungus and was treated with vorconizole. Imaging showed progressive destructive osteomyelitis at L3-L4. Patient underwent anterior L3 and L4 partial corpectomies, anterior interbody fusion L3-L5, and posterior T11-S2 pedicle screw and rod fixation. Antifungal treatment resulted in resolution of infection.Aspergillusmarkers remain negative. One year following definitive treatment, the patient’s back pain remains resolved.Conclusion. Definitive surgical resection of the infection, spinal stabilization, and aggressive antifungal therapy were required to eradicate the infection.
A novel natural tracer method to measure complex carbohydrate metabolism
Basu, Rita , Schiavon, Michele , Petterson, Xuan-Mai, Hinshaw, Ling , Slama, Michael , Carter, Rickey E. , Man, Chiara Dalla , Basu, Ananda , Carter, Rickey, Dalla Man, Chiara , Carter, Rickey E , Cobelli, Claudio , Schiavon, Michele

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | July 2, 2019 | Volume: 317 | Issue: 3 | Pages: E483-E493

10.1152/ajpendo.00133.2019 | PMID 31265327 Get It

While the triple tracer isotope dilution method has enabled accurate estimation of carbohydrate turnover after a mixed meal, use of the simple carbohydrate glucose as the carbohydrate source limits its translational applicability to everyday meals that typically contain complex carbohydrates. Hence, utilizing the natural enrichment of [13C]polysaccharide in commercially available grains, we devised a novel tracer method to measure postprandial complex carbohydrate turnover and indices of insulin action and β-cell function and compared the parameters to those obtained after a simple carbohydrate containing mixed meal. We studied healthy volunteers after either rice ( n = 8) or sorghum ( n = 8) and glucose ( n = 16) containing mixed meals and modified the triple tracer technique to calculate carbohydrate turnover. All meals were matched for calories and macronutrient composition. Rates of meal glucose appearance (2,658 ± 736 vs. 4,487 ± 909 μM·kg−1·2 h−1), endogenous glucose production (−835 ± 283 vs. −1,123 ± 323 μM·kg−1·2 h−1) and glucose disappearance (1,829 ± 807 vs. 3,606 ± 839 μM·kg−1·2 h−1) differed ( P < 0.01) between complex and simple carbohydrate containing meals, respectively. Interestingly, there were significant increase in indices of insulin sensitivity (32.5 ± 3.5 vs. 25.6 ± 3.2 10−5(dl·kg−1·min−2)/pM, P = 0.006) and β-cell responsivity (disposition index: 1,817 ± 234 vs. 1,236 ± 159 10−14(dl·kg−1·min−2)/pM, P < 0.005) with complex than simple carbohydrate meals. We present a novel triple tracer approach to estimate postprandial turnover of complex carbohydrate containing mixed meals. We also report higher insulin sensitivity and β-cell responsivity with complex than with simple carbohydrates in mixed meals of identical calorie and macronutrient compositions in healthy adults.